Detalles de la búsqueda
1.
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
N Engl J Med
; 390(13): 1163-1175, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598571
2.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37947974
3.
Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.
Strahlenther Onkol
; 200(6): 461-467, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38393398
4.
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 625-635, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35405088
5.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
6.
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Ann Surg
; 275(3): 576-581, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657944
7.
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy.
Breast Cancer Res Treat
; 193(3): 589-595, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35451733
8.
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Lancet Oncol
; 22(8): 1151-1161, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252375
9.
Association of TILs with clinical parameters, Recurrence Score® results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
Breast Cancer Res
; 22(1): 47, 2020 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32408905
10.
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
Cancer
; 126(22): 4847-4858, 2020 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780421
11.
Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Breast Cancer Res Treat
; 175(1): 265-266, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30632020
12.
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
Ann Surg Oncol
; 31(2): 1033-1034, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093166
13.
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
BMC Cancer
; 18(1): 851, 2018 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30144818
14.
Radiation Sensitivity of Adipose-Derived Stem Cells Isolated from Breast Tissue.
Int J Mol Sci
; 19(7)2018 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29986519
15.
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Breast Cancer Res Treat
; 165(3): 573-583, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28664507
16.
Letter to the Editor regarding the publication titled "Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?"
Breast Cancer Res Treat
; 186(1): 267-268, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415540
17.
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.
Mod Pathol
; 29(10): 1155-64, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27363491
18.
SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.
BMC Cancer
; 16: 337, 2016 05 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27234217
19.
Acute-phase proteins in prediction of preeclampsia in patients with abnormal midtrimester uterine Doppler velocimetry.
Arch Gynecol Obstet
; 294(6): 1151-1160, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27317435
20.
A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).
Cancer
; 121(20): 3639-48, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26111104